Study of gut microbial metabolites in chronic kidney disease
Part of Kidney & urinary, Women’s health & pregnancy clinical trials.
This trial studies how substances made by gut microbes travel in people with chronic kidney disease. You may be asked to have a planned colonoscopy so researchers can measure intestinal samples and better understand kidney disease.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You’re between 18 and 85 years old
- You have chronic kidney disease that is stage III or less, or you need dialysis
- You already have a colonoscopy scheduled for diagnostic reasons
- You can give written informed consent
- No significant history of gut disease such as inflammatory bowel disease
- No recent antibiotics or certain gut-transport/drug treatments in the 2 weeks before the colonoscopy
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study is collecting information from people with chronic kidney disease (CKD) to understand how the disease progresses over time. It does not test any new treatments, so you keep your usual care.
This is a long-term study that watches children and young adults with chronic kidney disease to understand how the illness changes and to improve care. You may be asked to complete regular visits and questionnaires, and your kidney function will be tracked over time.
This study collects health information from people with chronic kidney disease (CKD) and also from some people without CKD but with kidney risk factors. It helps doctors understand how CKD develops and how it’s managed in everyday life, not to test a new drug.
This study looks at how gut bacteria might affect weight loss in people with kidney failure who are on dialysis. It may help find new ways to prevent or treat weight loss in this condition.
This trial tests whether taking a probiotic supplement can slow down the decline of kidney function in people with moderate chronic kidney disease (CKD stages 3 and 4). If you have stable kidney disease and are not already taking probiotics, joining this study could help researchers find a new way to protect your kidneys.
This trial studies an oral product (a “uremic toxin” absorber) plus probiotics to help slow the progression of chronic kidney disease. It may help by lowering harmful gut-related substances that can build up when kidney function is reduced.
Hear when a new Chronic kidney disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.